(Q46711208)

English

Compartmental pharmacokinetics and tissue distribution of the antifungal triazole ravuconazole following intravenous administration of its di-lysine phosphoester prodrug (BMS-379224) in rabbits

scientific article published on 19 September 2005

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172108

Compartmental pharmacokinetics and tissue distribution of the antifungal triazole ravuconazole following intravenous administration of its di-lysine phosphoester prodrug (BMS-379224) in rabbits (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172108

pharmacokinetics

1 reference

based on heuristic

inferred from title

Ruta Petraitiene

4

object named as

Ruta Petraitiene

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172108

Vidmantas Petraitis

3

object named as

Vidmantas Petraitis

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172108

9

object named as

Thomas J Walsh

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172108

Diana Mickienė

2

object named as

Diana Mickiene

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172108

8

object named as

John Bacher

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172108

5

object named as

Amy Kelaher

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172108

Alia A Sarafandi

6

object named as

Alia Sarafandi

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172108

author name string

Andreas H Groll

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172108

Gudrun Wuerthwein

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172108

language of work or name

0 references

publication date

19 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172108

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172108

56

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172108

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172108

899-907

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172108

In vitro antifungal activity of BMS-207147 and itraconazole against yeast strains that are non-susceptible to fluconazole

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI287

21 January 2018

In vitro activity of the new triazole BMS-207147 against Aspergillus species in comparison with itraconazole and amphotericin B

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI287

21 January 2018

Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance P

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI287

21 January 2018

In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI287

21 January 2018

In vitro activities of ravuconazole (BMS-207147) against 541 clinical isolates of Cryptococcus neoformans

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI287

21 January 2018

Efficacy of ravuconazole in treatment of mucosal candidosis in SCID mice

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI287

21 January 2018

In vivo pharmacodynamics of a new triazole, ravuconazole, in a murine candidiasis model

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI287

21 January 2018

Efficacy of ravuconazole (BMS-207147) in a guinea pig model of disseminated aspergillosis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI287

21 January 2018

Efficacies of two new antifungal agents, the triazole ravuconazole and the echinocandin LY-303366, in an experimental model of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI287

21 January 2018

Efficacy, safety, and plasma pharmacokinetics of escalating dosages of intravenously administered ravuconazole lysine phosphoester for treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbits

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI287

21 January 2018

Efficacy of ravuconazole in treatment of systemic murine histoplasmosis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI287

21 January 2018

Clinical pharmacology of antifungal compounds

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI287

21 January 2018

Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI287

21 January 2018

Penetration of ravuconazole, a new triazole antifungal, into rat tissues

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI287

21 January 2018

Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI287

21 January 2018

Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI287

21 January 2018

Identifiers

10.1093/JAC/DKI287

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172108

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16172108

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46711208&oldid=2144511638"